GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Cyclically Adjusted PS Ratio

Deinove (XPAR:ALDEI) Cyclically Adjusted PS Ratio : 0.88 (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Deinove Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Deinove's current share price is €0.0265. Deinove's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec21 was €0.03. Deinove's Cyclically Adjusted PS Ratio for today is 0.88.

The historical rank and industry rank for Deinove's Cyclically Adjusted PS Ratio or its related term are showing as below:

XPAR:ALDEI's Cyclically Adjusted PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 5.505
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Deinove's adjusted revenue per share data of for the fiscal year that ended in Dec21 was €0.013. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.03 for the trailing ten years ended in Dec21.

Shiller PE for Stocks: The True Measure of Stock Valuation


Deinove Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Deinove's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Cyclically Adjusted PS Ratio Chart

Deinove Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 23.63 11.73 15.06 11.94

Deinove Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 15.06 - 11.94 -

Competitive Comparison of Deinove's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Deinove's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deinove's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Deinove's Cyclically Adjusted PS Ratio falls into.



Deinove Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Deinove's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0265/0.03
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deinove's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec21 is calculated as:

For example, Deinove's adjusted Revenue per Share data for the fiscal year that ended in Dec21 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec21 (Change)*Current CPI (Dec21)
=0.013/107.8500*107.8500
=0.013

Current CPI (Dec21) = 107.8500.

Deinove Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201212 0.135 99.100 0.147
201312 0.010 99.800 0.011
201412 0.029 99.860 0.031
201512 0.057 100.040 0.061
201612 0.031 100.650 0.033
201712 0.007 101.850 0.007
201812 0.003 103.470 0.003
201912 0.010 104.980 0.010
202012 0.013 104.960 0.013
202112 0.013 107.850 0.013

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Deinove  (XPAR:ALDEI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Deinove Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Deinove's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Deinove (XPAR:ALDEI) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790
Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines